Literature DB >> 15023561

Inhibition of the pentose phosphate pathway decreases ischemia-reperfusion-induced creatine kinase release in the heart.

C J Zuurbier1, O Eerbeek, P T Goedhart, E A Struys, N M Verhoeven, C Jakobs, C Ince.   

Abstract

OBJECTIVE: The oxidative pentose phosphate pathway (oxPPP) produces NADPH, which can be used to maintain glutathione in its reduced state (anti-oxidant; beneficial effects) or to produce radicals or nitric oxide (NO) through NADPH oxidase/NO synthase (detrimental effects). Changes in cytosolic redox status have been implicated in ischemic preconditioning (PC). This study investigates whether (1) PC affects mitochondrial redox state, (2) the oxPPP plays a protective or detrimental role in ischemia (I)-reperfusion (R) injury in the intact heart and (3) PPP is altered with PC.
METHODS: Isolated rat hearts were subjected to 40-min global I and 30-min R (CO, control). Ischemia was either preceded by three 5-min I/R periods (PC) and/or oxPPP inhibition by 6-aminonicotinamide (6AN) or NADPH oxidase/NO synthase inhibition by diphenyleneiodonium (DPI). NADH videofluorometry was used to determine mitochondrial redox state. PPP intermediates were determined in CO and PC hearts using tandem mass spectrometry.
RESULTS: PC reduced ischemic damage (creatine kinase, CK, release from 337+/-64 to 147+/-41 U/R/gdw) and contracture (from 59+/-5 to 31+/-3 mm Hg) and increased recovery of contractility (from 48+/-10% to 88+/-8%), as compared to CO. PC was without effect on NADH fluorometry. Inhibition of the oxPPP reduced injury (CK release: 91+/-24 U/R/gdw) to similar levels as PC, without improving contractility. Inhibition of NADPH oxidase/NO synthase mimicked the effects of oxPPP inhibition on injury (CK release: 140+/-22 U/R/gdw). Although levels of ribose-5P and (ribulose-5P+xylulose-5P) rose several fold during ischemia with minor changes in sedoheptulose-7P, demonstrating an active PPP in the heart, PC did not affect these levels.
CONCLUSIONS: (1) PC can attenuate cardiac reperfusion injury without alterations in mitochondrial redox state; (2) inhibition of the oxPPP protects the heart against I/R-induced CK release; and (3) PC does not result in altered activity of the PPP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023561     DOI: 10.1016/j.cardiores.2004.01.010

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

1.  Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.

Authors:  Claudio Vimercati; Khaled Qanud; Gianfranco Mitacchione; Danuta Sosnowska; Zoltan Ungvari; Roberto Sarnari; Daniella Mania; Neel Patel; Thomas H Hintze; Sachin A Gupte; William C Stanley; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

2.  Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.

Authors:  Rakhee S Gupte; Beverly C Floyd; Mark Kozicky; Shimran George; Zoltan I Ungvari; Vanessa Neito; Michael S Wolin; Sachin A Gupte
Journal:  Free Radic Biol Med       Date:  2009-02-20       Impact factor: 7.376

Review 3.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 4.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

5.  Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice.

Authors:  Kirsten M Smeele; Otto Eerbeek; Anneke Koeman; Rick Bezemer; Can Ince; Sami Heikkinen; Markku Laakso; Arnold de Haan; Gert Schaart; Maarten R Drost; Markus W Hollmann; Coert J Zuurbier
Journal:  Pflugers Arch       Date:  2010-02-25       Impact factor: 3.657

Review 6.  Cardioprotection by metabolic shut-down and gradual wake-up.

Authors:  Lindsay S Burwell; Sergiy M Nadtochiy; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2009-03-10       Impact factor: 5.000

7.  Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.

Authors:  Sabrina Serpillon; Beverly C Floyd; Rakhee S Gupte; Shimran George; Mark Kozicky; Venessa Neito; Fabio Recchia; William Stanley; Michael S Wolin; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

8.  Ischemic preconditioning and diazoxide limit mitochondrial Ca overload during ischemia/reperfusion: Role of reactive oxygen species.

Authors:  Matt Eaton; Lisa A Hernandez; Saul Schaefer
Journal:  Exp Clin Cardiol       Date:  2005

Review 9.  Mitochondrial hexokinase and cardioprotection of the intact heart.

Authors:  C J Zuurbier; K M A Smeele; O Eerbeek
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 10.  Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

Authors:  Rianne Nederlof; Otto Eerbeek; Markus W Hollmann; Richard Southworth; Coert J Zuurbier
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.